Celerion Is A Global Contract Research Organizationcrothat Specializes In Early Phase Clinical Research Services For The Biopharmaceutical Industryestablished In 2010 Through The Acquisition Of Mds Pharma Servicesearly Stage Development Operationscelerion Has Roots Dating Back To 1933 With Harris Laboratories In Lincolnnebraskathe Company Is Dedicated To Translating Scientific Discoveries Into Market Ready Therapiesemphasizing Speed In Drug Development From Early Clinical Trials To Proof Of Concept Celerion Offers A Range Of Early Phase Clinical Research Servicesincluding First In Human Trialsbioequivalence Studiespharmacokinetic Pharmacodynamic Modelingcardiovascular Safety Assessmentsand Regulatory Support For Drug Approval Processesthe Company Is Known For Its Scientific Expertise And Proprietary Methodologieswhich Enhance Decision Making And Optimize Trial Designscelerion Partners With Biopharmaceutical Innovators And Has Played A Significant Role In Clinical Studies For Numerous Fda Approved Drugsshowcasing Its Impact On Bringing New Therapies To Market
United States
